EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Triazeneindole Antibiotics: Synthesis and Hit-to-Lead Optimization

Boris Sorokin iD, Alla Filimonova, Anna Emelianova, Vadim Kublitski iD, Artem Gvozd, Vladimir Shmygarev, Ilia Yampolsky, Elena Guglya iD, Evgeniy Gusev, Denis Kuzmin

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26051870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Boris Sorokin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Moscow Center for Advanced Studies, Kulakova Str. 20, 123592 Moscow, Russia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus, Indoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial antibiotic resistance represents a major healthcare problem. In 2019, 4.95 million deaths were associated with antibiotic resistance, and it is estimated that, by 2050, up to 3.8% of the global gross domestic product could be lost due to this problem. Methicillin-resistant Staphylococcus aureus is one of the leading sources of hospital-acquired infections associated with increased mortality, length of hospital stay, and higher cost of treatment. Here, we describe the de novo synthesis of a library of 22 triazeneindole derivatives with high activity against a wide panel of multidrug-resistant MRSA clinical isolates. Leading compound BX-SI043 (ethyl 6-fluoro-3-[pyrrolidin-1-yl-azo]-1H-indole-2-carboxylate) showed high activity (minimal inhibitory concentration range, 0.125–0.5 mg/L) against 41 multidrug-resistant MRSA strains, as well as relatively low in vitro cytotoxicity (selectivity index, 76) and in vivo acute toxicity (maximum tolerated dose, 600 mg/kg), via intragastric administration in rats. These data suggest that BX-SI043 is a promising drug candidate for the development a novel MRSA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusIndolesAnimalsMicrobial Sensitivity TestsRatsHumansStaphylococcal InfectionsDrug Resistance, Multiple, BacterialMale

Stichwörter der Autor:innen

ABSSSIADME-ToxMRSAantibiotichit-to-leadtriazeneindole

Substanzen

Anti-Bacterial AgentsIndoles

Autor:innen und Institutionen

  • Moscow Center for Advanced Studies, Kulakova Str. 20, 123592 Moscow, Russia.
  • Kurchatov Centre for Genome Research, National Research Centre "Kurchatov Institute", 123182 Moscow, Russia.
  • Institute for Personalized Oncology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
  • Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Severtsov Institute of Ecology and Evolution, Russian Academy of Sciences, Leninsky Prospect 33, 119071 Moscow, Russia.

ORCID-Profile: Boris Sorokin, Vadim Kublitski, Elena Guglya

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Sorokin, B., Filimonova, A., Emelianova, A., Kublitski, V., Gvozd, A., Shmygarev, V., Yampolsky, I., Guglya, E., Gusev, E., & Kuzmin, D. (2025). Novel Triazeneindole Antibiotics: Synthesis and Hit-to-Lead Optimization. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26051870

Vancouver

Sorokin B, Filimonova A, Emelianova A, Kublitski V, Gvozd A, Shmygarev V, et al. Novel Triazeneindole Antibiotics: Synthesis and Hit-to-Lead Optimization. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26051870

BibTeX
@article{Sorokin2025,
  author = {Sorokin, Boris and Filimonova, Alla and Emelianova, Anna and Kublitski, Vadim and Gvozd, Artem and Shmygarev, Vladimir and Yampolsky, Ilia and Guglya, Elena and Gusev, Evgeniy and Kuzmin, Denis},
  title = {Novel Triazeneindole Antibiotics: Synthesis and Hit-to-Lead Optimization},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26051870}
}
Kostenlos starten →